Research
Education
Healthcare
Community
About
Jul 01, 2026 | ProBio Inc.
ProBio's AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class Pan-Cancer CAR‑T Program
UC Irvine researchers and GlyTR Therapeutics have advanced a groundbreaking, first-in-class pan-cancer CAR-T platform with the potential to expand the reach of cell therapy into solid tumors.
Jun 23, 2026 | UC Irvine School of Medicine
Researchers Develop a Potential Blood Test for Diagnosing ALS
UC Irvine researchers are part of an international team developing a new blood test to diagnose ALS and track its progression.
Jun 18, 2026 | UC Irvine School of Medicine
CBD to Alleviate ‘Chemo Brain’ in Cancer Survivors
A new study by UC Irvine researchers suggests that CBD can help treat “brain fog” for people with cancer-therapy-related cognitive impairments (CRCI), addressing an unmet medical need.
Matt Miller Director mrmille2@uci.edu
Michelle Heath Manager mstrombe@hs.uci.edu
Shani Murray Senior Science Writer shanim@hs.uci.edu
Communications & PR Office
Stay Connected
UC Irvine researchers Vivek Swarup, PhD, and Elizabeth Head, PhD, have received a major new award from the NIH to investigate a striking connection between Down syndrome and Alzheimer’s disease — research that could ultimately improve our understanding of Alzheimer’s for everyone.
How does the Epstein-Barr Virus (EBV) manipulate our immune cells during initial infection? A new “human-tonsil-in-a-dish” model offers insights.
As a young teen, Lara Taniguchi spotted a flyer recruiting volunteers to help children with disabilities learn to swim, setting in motion her journey to better understand how our brains work.
Aug 11, 2026 | National Institutes of Health
Childhood Screen Detects Mental Health Risk
An NIH-funded research team led by Dr. Tallie Z. Baram at the University of California, Irvine and Dr. Laura Glynn at Chapman University …. added five unpredictability measures to a current adversity screen. They tested whether these measures helped improve the detection of childhood mental health conditions.
Aug 11, 2026 | NBC San Diego
UC Irvine Research Study How Ibogaine May Help Treat Opioid Addiction
Researchers at UC Irvine are trying to answer one of the biggest questions about ibogaine, a psychedelic that is still illegal in the United States, but which is increasingly becoming a focus for scientists trying to unlock its potential healing power. Professor Rick Harris is the neuroscientist leading the effort, working with volunteers. “Our group is trying to understand how the ibogaine might be working to break addictive circuitry” he says